ENDRA Life Sciences (NDRA) Other financing activities (2016 - 2025)

ENDRA Life Sciences (NDRA) has 5 years of Other financing activities data on file, last reported at $2028.0 in Q4 2025.

• Other financing activities for Q4 2025 came in at $2028.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $262804.0 (changed N/A YoY), and the FY2025 annual result was $35953.0, changed N/A from the prior year.
• Other financing activities slipped to $2028.0 in Q4 2025 per NDRA's latest filing, from $260776.0 in the prior quarter.
• Over five years, Other financing activities peaked at $260776.0 in Q1 2023 and troughed at $2028.0 in Q4 2025.
• A 4-year average of $106726.4 and a median of $26783.0 in 2022 frame the typical range for Other financing activities.
• On a YoY basis, Other financing activities climbed as much as 873.66% in 2023 and fell as far as 873.66% in 2023.
• A 4-year view of Other financing activities shows it stood at $10052.0 in 2021, then surged by 2227.83% to $233993.0 in 2022, then grew by 11.45% to $260776.0 in 2023, then slumped by 99.22% to $2028.0 in 2025.
• Business Quant data shows NDRA's Other financing activities at $2028.0 in Q4 2025, $260776.0 in Q1 2023, and $233993.0 in Q2 2022.